Ultimate magazine theme for WordPress.

Results from EMPEROR-Preserved, alcohol consumption and more

September 01, 2021

Read for 2 minutes

ADD SUBJECT TO EMAIL ALERTS

Receive an email when new articles are published on

Please enter your email address to receive an email when new articles are published on . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If this problem persists, please contact [email protected]

Back to Healio

Healio and Cardiology Today have compiled a list of the most-read cardiology news of August 2021.

Readers were interested in the potential CV benefits of moderate alcohol consumption; Findings from KAISER preservation; the effects of sedentary leisure time on stroke risk; and more.

Latest newsSource: Adobe Stock

Moderate alcohol consumption associated with reduced CV mortality, events

Moderate alcohol consumption was associated with a reduced risk of both cardiovascular mortality and events in patients with CVD, according to a study published in BMC Medicine. Continue reading

Testosterone therapy can reduce cardiovascular events and mortality in men with very low hormone levels

Long-term testosterone therapy significantly reduced heart attack and stroke events in men with abnormally low testosterone levels, according to new data presented at the European Association of Urology Congress. Continue reading

Certain oral contraceptives increase the cardiac risk in women with long QT syndrome

Women with long-term QT ​​syndrome who took progestin-only oral contraceptives had an increased risk of cardiac events, according to a study presented at Heart Rhythm 2021. Continue reading

Consumption of plant-based foods linked to a lower risk of CVD

According to two studies published in the Journal of the American Heart Association, a more plant-centered diet was associated with a lower risk of cardiovascular disease in both young adults and postmenopausal women. Continue reading

Sedentary leisure time of at least 8 hours per day has been linked to stroke risk in younger adults

Among adults under 60 with low physical activity, those who had at least 8 hours of sedentary leisure time per day were at increased risk of stroke, according to results published in Stroke. Continue reading

Beta blocker therapy for 1 year after MI failed to improve survival

Beta-blocker therapy did not improve survival beyond 1 year after myocardial infarction, although a dose-dependent effect was observed, according to a landmark analysis of the OBTAIN registry. Continue reading

Empagliflozin is the first active ingredient to improve results in HFpEF: EMPEROR-Preserved

The expected results of the EMPEROR-Preserved study show that the SGLT2 inhibitor empagliflozin improved clinical outcomes in patients with HI with preserved ejection fraction – the first drug to be shown to do so. Continue reading

FDA approves empagliflozin for the treatment of HFrEF in patients with or without diabetes

Boehringer Ingelheim and Eli Lilly announced that the FDA has approved empagliflozin for reducing the risk of cardiovascular death and HF hospitalization in adults with HF with reduced ejection fraction, whether or not they have diabetes. Continue reading

Addition of dapagliflozin to drug therapy effective and inexpensive for HFrEF

In a simulation model, the addition of dapagliflozin to guideline medical therapy in patients with HI with reduced ejection fraction improved long-term clinical outcomes and was cost-effective at current US prices. Continue reading

There are many factors to consider when choosing an imaging test for chest pain

For patients with chest pain, there isn’t a single imaging test that provides the perfect diagnosis for all, according to a spokesman for the American Society for Preventive Cardiology Congress on CVD Prevention. Continue reading

ADD SUBJECT TO EMAIL ALERTS

Receive an email when new articles are published on

Please enter your email address to receive an email when new articles are published on . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If this problem persists, please contact [email protected]

Back to Healio

Comments are closed.